4th Annual Gene Therapy Immunogenicity Summit 2023

The complex and multifaceted manifestations of immunogenicity associated with AAV gene therapy administration pose critical risk to patient safety and product efficacy. Unlocking the full therapeutic potential of these products requires a concerted effort to better understand and address the underlying mechanisms of this response.